This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Bayer Intellectual Property Gmbh, Bayer Pharma Aktiengesellschaft. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 721 
2 out of 387 
Years Active: 2017-2019
Title: **Jan-Georg Peters: Innovator in Pharmaceutical Chemistry**
Introduction
Jan-Georg Peters is a prominent inventor based in Solingen, Germany, known for his significant contributions to the field of pharmaceutical chemistry. With a total of four patents to his name, Peters has dedicated his career to developing innovative methods and compounds that hold promise for therapeutic applications.
Latest Patents
Among his latest patents, one notable invention is the "Synthesis of copanlisib and its dihydrochloride salt." This invention outlines a novel method of preparing copanlisib, its dihydrochloride form, and associated hydrates. The invention also identifies novel intermediate compounds used in the synthesis of these derivatives. Another significant patent is titled "Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts." This patent describes a specific dihydrochloride salt of a complex pyrimidine compound, detailing methods for its preparation and its applications in treating a variety of cancers, including lung cancer and breast cancer. Such advancements demonstrate Peters' focus on addressing critical health challenges through innovative chemistry.
Career Highlights
Throughout his career, Jan-Georg Peters has worked with notable organizations, including Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His role in these companies allowed him to leverage his expertise in pharmaceutical research, significantly contributing to the development of new medicinal compounds.
Collaborations
Peters has collaborated with esteemed colleagues such as Hans-Christian Militzer and Hartwig Müller. These partnerships have facilitated the exchange of ideas and expertise, fostering an environment for innovative research and development in pharmaceutical science.
Conclusion
Jan-Georg Peters' contributions to the field of pharmaceutical chemistry are underscored by his innovative patents and collaborative efforts. His work continues to pave the way for advancements in medical treatments, showcasing the vital role of inventors in enhancing health outcomes through research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile